Trial intelligence / Profile preview

Varenicline for Tobacco Dependence in Recovering Alcoholic Smokers

NCT01092702Phase 3Completed

Sponsor
Mayo Clinic
Start
Apr 2008
Primary completion
Sep 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of varenicline in tobacco dependence, sponsored by Mayo Clinic. Started Apr 2008; status: completed.

02

Drugs

varenicline
03

Conditions

tobacco dependence

Beyond the preview

Go deeper on NCT01092702.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01092702.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call